EBIT: Income before interest and taxes.
Allarity Therapeutics, Inc. (ALLR) had EBIT of $-2.92M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-3.37M |
|
-- |
|
-- |
|
$3.24M |
|
$-3.24M |
|
$-0.46M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
$-3.37M |
|
|
EBIT |
$-2.92M |
$-3.23M |
|
14.38M |
|
14.38M |
|
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$17.93M |
|
$0.33M |
|
$0.33M |
|
$18.26M |
|
$8.43M |
|
-- |
|
-- |
|
$8.43M |
|
$9.83M |
|
$9.83M |
|
$9.83M |
|
16.08M |
|
| Cash Flow Statement Financials | |
$-14.82M |
|
$-0.01M |
|
$10.65M |
|
$19.53M |
|
$14.69M |
|
$-4.85M |
|
$0.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.13 |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-14.83M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-34.32% |
|
-34.32% |
|
-18.47% |
|
-34.32% |
|
$0.61 |
|
$-1.03 |
|
$-1.03 |
|